SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-465472
Filing Date
2012-11-13
Accepted
2012-11-13 07:01:14
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d422812d10q.htm 10-Q 480949
2 CERTIFICATIONS BY CEO PURSUANT TO SECTION 302 d422812dex311.htm EX-31.1 6198
3 CERTIFICATIONS BY CFO PURSUANT TO SECTION 302 d422812dex312.htm EX-31.2 6176
4 CERTIFICATIONS BY CEO AND CFO PURSUANT TO SECTION 906 d422812dex321.htm EX-32.1 4319
  Complete submission text file 0001193125-12-465472.txt   4675735

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20120930.xml EX-101.INS 725525
6 XBRL TAXONOMY EXTENSION SCHEMA gale-20120930.xsd EX-101.SCH 62231
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gale-20120930_cal.xml EX-101.CAL 61549
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gale-20120930_def.xml EX-101.DEF 233217
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gale-20120930_lab.xml EX-101.LAB 384499
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gale-20120930_pre.xml EX-101.PRE 281163
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 121195547
SIC: 2834 Pharmaceutical Preparations